Professor Maria Zambon
Professor Maria Zambon
Verified email at phe.gov.uk
Title
Cited by
Cited by
Year
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
VM Corman, O Landt, M Kaiser, R Molenkamp, A Meijer, DKW Chu, ...
Eurosurveillance 25 (3), 2000045, 2020
30292020
Re-emergence of fatal human influenza A subtype H5N1 disease
JSM Peiris, WC Yu, CW Leung, CY Cheung, WF Ng, JM Nicholls, TK Ng, ...
The Lancet 363 (9409), 617-619, 2004
10312004
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome
T Kuiken, RAM Fouchier, M Schutten, GF Rimmelzwaan, ...
The Lancet 362 (9380), 263-270, 2003
10132003
Commentary: Middle east respiratory syndrome coronavirus (mers-cov): announcement of the coronavirus study group
RJ De Groot, SC Baker, RS Baric, CS Brown, C Drosten, L Enjuanes, ...
Journal of virology 87 (14), 7790-7792, 2013
10042013
Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study
E Miller, K Hoschler, P Hardelid, E Stanford, N Andrews, M Zambon
The Lancet 375 (9720), 1100-1108, 2010
8232010
Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction
VM Corman, I Eckerle, T Bleicker, A Zaki, O Landt, M Eschbach-Bludau, ...
Eurosurveillance 17 (39), 20285, 2012
5822012
Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza
KG Nicholson, AE Colegate, A Podda, I Stephenson, J Wood, E Ypma, ...
The Lancet 357 (9272), 1937-1943, 2001
5012001
Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012
A Bermingham, MA Chand, CS Brown, E Aarons, C Tong, C Langrish, ...
Eurosurveillance 17 (40), 20290, 2012
4962012
Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial
JL Bresson, C Perronne, O Launay, C Gerdil, M Saville, J Wood, ...
The Lancet 367 (9523), 1657-1664, 2006
4842006
Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007–08 season
A Meijer, A Lackenby, O Hungnes, B Lina, S van der Werf, B Schweiger, ...
Emerging infectious diseases 15 (4), 552, 2009
4422009
Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study
MC Zambon, JD Stockton, JP Clewley, DM Fleming
The Lancet 358 (9291), 1410-1416, 2001
4272001
Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use
AS Monto, JL McKimm-Breschkin, C Macken, AW Hampson, A Hay, ...
Antimicrobial agents and chemotherapy 50 (7), 2395-2402, 2006
4182006
Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir
J McKimm-Breschkin, T Trivedi, A Hampson, A Hay, A Klimov, M Tashiro, ...
Antimicrobial agents and chemotherapy 47 (7), 2264-2272, 2003
3862003
Human metapneumovirus as a cause of community-acquired respiratory illness
J Stockton, I Stephenson, D Fleming, M Zambon
Emerging infectious diseases 8 (9), 897, 2002
3832002
Emergence of resistance to oseltamivir among influenza A (H1N1) viruses in Europe
A Lackenby, O Hungnes, SG Dudman, A Meijer, WJ Paget, AJ Hay, ...
Eurosurveillance 13 (5), 3-4, 2008
3752008
Multiplex PCR for typing and subtyping influenza and respiratory syncytial viruses
J Stockton, JS Ellis, M Saville, JP Clewley, MC Zambon
Journal of clinical microbiology 36 (10), 2990-2995, 1998
3721998
Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study
AC Hayward, EB Fragaszy, A Bermingham, L Wang, A Copas, ...
The Lancet Respiratory Medicine 2 (6), 445-454, 2014
3502014
Epidemiology and pathogenesis of influenza
MC Zambon
Journal of Antimicrobial Chemotherapy 44 (suppl_2), 3-9, 1999
3371999
Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a …
I Stephenson, R Bugarini, KG Nicholson, A Podda, JM Wood, MC Zambon, ...
The Journal of infectious diseases 191 (8), 1210-1215, 2005
3352005
Invariant NKT cells reduce the immunosuppressive activity of influenza A virus–induced myeloid-derived suppressor cells in mice and humans
C De Santo, M Salio, SH Masri, LYH Lee, T Dong, AO Speak, S Porubsky, ...
The Journal of clinical investigation 118 (12), 4036-4048, 2008
3202008
The system can't perform the operation now. Try again later.
Articles 1–20